Accordingly, one of its members, MEF2D, has been related to lung cancer (Zhang et al., 2015), hepatocellular carcinoma (Ma et al., 2014), and glioma (Zhao et al., 2015), with its expression regulated by miR‐1244, miR‐122, and miR‐18a, respectively. This evidence concerns the gene MEF2D and hepatocellular carcinoma.